Process View
Any process that modulates the frequency, rate or extent of cyclin-dependent protein serine/threonine kinase activity.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "regulation of cyclin dependent protein serine threonine kinase activity"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | 1.000 | Mouse | |
| FGFR2 | fibroblast growth factor receptor 2 | 0.996 | ||
| CCND3 | cyclin D3 | 0.996 | ||
| CCND1 | cyclin D1 | 0.995 | ||
| EGFR | epidermal growth factor receptor | 0.990 | ||
| CDK6 | cyclin-dependent kinase 6 | 0.989 | ||
| CDK2 | cyclin-dependent kinase 2 | 0.988 | ||
| RARA | retinoic acid receptor, alpha | 0.951 | ||
| MDM2 | Mdm2 p53 binding protein homolog (mouse) | 0.944 | ||
| JUN | jun proto-oncogene | 0.941 | ||
| SRF | serum response factor (c-fos serum response element-binding transcription factor) | 0.933 | ||
| DLG1 | discs, large homolog 1 (Drosophila) | 0.931 | ||
| CDK14 | cyclin-dependent kinase 14 | 0.882 | ||
| RB1 | retinoblastoma 1 | 0.849 | ||
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.746 | ||
| FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.738 | ||
| ABI2 | abl-interactor 2 | 0.708 | ||
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.702 | ||
| JUNB | jun B proto-oncogene | 0.700 | ||
| FGFR1 | fibroblast growth factor receptor 1 | 0.669 | ||
| CCNE1 | cyclin E1 | 0.663 | ||
| CREBBP | CREB binding protein | 0.645 | ||
| ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 0.616 | Human | |
| CDK4 | cyclin-dependent kinase 4 | 0.607 | ||
| CDKN1B | cyclin-dependent kinase inhibitor 1B (p27, Kip1) | 0.585 | Mouse | |
| UBC | ubiquitin C | 0.578 | ||
| PLCG1 | phospholipase C, gamma 1 | 0.568 | ||
| ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase | 0.565 | ||
| CDKN2A | cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) | 0.475 | ||
| ATF3 | activating transcription factor 3 | 0.474 | Fly | |
| FOS | FBJ murine osteosarcoma viral oncogene homolog | 0.471 | Fly | |
| LARP7 | La ribonucleoprotein domain family, member 7 | 0.455 | ||
| CDK9 | cyclin-dependent kinase 9 | 0.438 | ||
| NCOA3 | nuclear receptor coactivator 3 | 0.406 | ||
| FGF1 | fibroblast growth factor 1 (acidic) | 0.375 | Human | |
| CENPJ | centromere protein J | 0.344 | ||
| UHRF2 | ubiquitin-like with PHD and ring finger domains 2 | 0.335 | ||
| IKBKG | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma | 0.301 | ||
| CDC27 | cell division cycle 27 homolog (S. cerevisiae) | 0.298 | ||
| MOBKL1A | MOB1, Mps One Binder kinase activator-like 1A (yeast) | 0.277 | ||
| FGF10 | fibroblast growth factor 10 | 0.272 | ||
| IRF2BP1 | interferon regulatory factor 2 binding protein 1 | 0.263 | ||
| JUND | jun D proto-oncogene | 0.256 | ||
| ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 0.250 | Human | |
| MED25 | mediator complex subunit 25 | 0.243 | ||
| CKS1B | CDC28 protein kinase regulatory subunit 1B | 0.242 | ||
| CDC37 | cell division cycle 37 homolog (S. cerevisiae) | 0.234 | ||
| SPRR2A | small proline-rich protein 2A | 0.232 | ||
| PKD1 | polycystic kidney disease 1 (autosomal dominant) | 0.219 | ||
| CASP9 | caspase 9, apoptosis-related cysteine peptidase | 0.217 | ||
| CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 0.217 | ||
| CCNA2 | cyclin A2 | 0.216 | ||
| CDC20 | cell division cycle 20 homolog (S. cerevisiae) | 0.216 | ||
| NCOR2 | nuclear receptor corepressor 2 | 0.213 | ||
| NOXA1 | NADPH oxidase activator 1 | 0.208 | ||
| FYN | FYN oncogene related to SRC, FGR, YES | 0.205 | ||
| CDK1 | cyclin-dependent kinase 1 | 0.202 | ||
| CDC25C | cell division cycle 25 homolog C (S. pombe) | 0.187 | ||
| PRKCZ | protein kinase C, zeta | 0.185 | Human | |
| BCL3 | B-cell CLL/lymphoma 3 | 0.180 | ||
| CCNH | cyclin H | 0.177 | ||
| IER2 | immediate early response 2 | 0.175 | ||
| RUNX1 | runt-related transcription factor 1 | 0.171 | ||
| PRNP | prion protein | 0.158 | ||
| BHLHE40 | basic helix-loop-helix family, member e40 | 0.157 | ||
| MNAT1 | menage a trois homolog 1, cyclin H assembly factor (Xenopus laevis) | 0.156 | ||
| LATS2 | LATS, large tumor suppressor, homolog 2 (Drosophila) | 0.153 | ||
| NEDD4 | neural precursor cell expressed, developmentally down-regulated 4 | 0.152 | ||
| CHEK2 | CHK2 checkpoint homolog (S. pombe) | 0.150 | ||
| PKD2 | polycystic kidney disease 2 (autosomal dominant) | 0.150 | ||
| TRPC1 | transient receptor potential cation channel, subfamily C, member 1 | 0.142 | ||
| PSMD2 | proteasome (prosome, macropain) 26S subunit, non-ATPase, 2 | 0.142 | ||
| BCAR1 | breast cancer anti-estrogen resistance 1 | 0.135 | ||
| NCOA1 | nuclear receptor coactivator 1 | 0.133 | ||
| PPP1CC | protein phosphatase 1, catalytic subunit, gamma isozyme | 0.133 | ||
| DDIT3 | DNA-damage-inducible transcript 3 | 0.132 | ||
| MAPRE2 | microtubule-associated protein, RP/EB family, member 2 | 0.128 | ||
| CDKN2C | cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) | 0.126 | ||
| MAFF | v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian) | 0.126 | ||
| BTRC | beta-transducin repeat containing | 0.126 | ||
| CCNB2 | cyclin B2 | 0.125 | Yeast | |
| MDM4 | Mdm4 p53 binding protein homolog (mouse) | 0.123 | ||
| NCF1 | neutrophil cytosolic factor 1 | 0.121 | ||
| VEGFA | vascular endothelial growth factor A | 0.117 | Human | |
| EP300 | E1A binding protein p300 | 0.115 | ||
| SKP1 | S-phase kinase-associated protein 1 | 0.114 | ||
| TP53 | tumor protein p53 | 0.113 | ||
| CDKN2B | cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) | 0.108 | ||
| BRCA2 | breast cancer 2, early onset | 0.104 | ||
| SKP2 | S-phase kinase-associated protein 2 (p45) | 0.104 | ||
| SNAI1 | snail homolog 1 (Drosophila) | 0.102 | ||
| KLF6 | Kruppel-like factor 6 | 0.100 | ||
| PPP1R15A | protein phosphatase 1, regulatory (inhibitor) subunit 15A | 0.099 | ||
| XIAP | X-linked inhibitor of apoptosis | 0.096 | ||
| CCND2 | cyclin D2 | 0.094 | ||
| FOSL1 | FOS-like antigen 1 | 0.093 | Fly | |
| SNX33 | sorting nexin 33 | 0.093 | ||
| CCNB1 | cyclin B1 | 0.090 | Yeast | |
| NR0B2 | nuclear receptor subfamily 0, group B, member 2 | 0.090 | ||
| PPARGC1A | peroxisome proliferator-activated receptor gamma, coactivator 1 alpha | 0.088 | ||
| APP | amyloid beta (A4) precursor protein | 0.088 | ||
| SFN | stratifin | 0.087 | Mouse | |
| NPHP1 | nephronophthisis 1 (juvenile) | 0.086 | ||
| FOXM1 | forkhead box M1 | 0.084 | ||
| RELA | v-rel reticuloendotheliosis viral oncogene homolog A (avian) | 0.083 | ||
| PAG1 | phosphoprotein associated with glycosphingolipid microdomains 1 | 0.083 | ||
| APAF1 | apoptotic peptidase activating factor 1 | 0.081 | ||
| SH3D19 | SH3 domain containing 19 | 0.081 | ||
| DDX21 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 21 | 0.080 | ||
| CASP3 | caspase 3, apoptosis-related cysteine peptidase | 0.079 | Mouse | |
| PML | promyelocytic leukemia | 0.079 | ||
| YWHAB | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide | 0.078 | ||
| KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.076 | ||
| NR3C1 | nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.073 | ||
| YWHAQ | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta polypeptide | 0.072 | ||
| FGF7 | fibroblast growth factor 7 | 0.072 | Human | |
| PIK3R2 | phosphoinositide-3-kinase, regulatory subunit 2 (beta) | 0.069 | ||
| CHEK1 | CHK1 checkpoint homolog (S. pombe) | 0.067 | ||
| STK4 | serine/threonine kinase 4 | 0.067 | ||
| PIM1 | pim-1 oncogene | 0.067 | ||
| NR4A2 | nuclear receptor subfamily 4, group A, member 2 | 0.066 | ||
| SMAD1 | SMAD family member 1 | 0.064 | ||
| LMO2 | LIM domain only 2 (rhombotin-like 1) | 0.063 | ||
| MAPT | microtubule-associated protein tau | 0.063 | ||
| YAP1 | Yes-associated protein 1 | 0.062 | ||
| CTNNB1 | catenin (cadherin-associated protein), beta 1, 88kDa | 0.061 | ||
| ZFP36 | zinc finger protein 36, C3H type, homolog (mouse) | 0.061 | ||
| CDC25B | cell division cycle 25 homolog B (S. pombe) | 0.059 | ||
| LCK | lymphocyte-specific protein tyrosine kinase | 0.059 | ||
| BUB1B | budding uninhibited by benzimidazoles 1 homolog beta (yeast) | 0.059 | ||
| CCNA1 | cyclin A1 | 0.056 | ||
| CKS2 | CDC28 protein kinase regulatory subunit 2 | 0.053 | ||
| CDKN2D | cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4) | 0.052 | ||
| SH3PXD2A | SH3 and PX domains 2A | 0.051 | ||
| PDGFC | platelet derived growth factor C | 0.046 | ||
| PRKCB | protein kinase C, beta | 0.046 | ||
| STK3 | serine/threonine kinase 3 | 0.045 | ||
| CDC25A | cell division cycle 25 homolog A (S. pombe) | 0.045 | ||
| SNX9 | sorting nexin 9 | 0.045 | ||
| CUX1 | cut-like homeobox 1 | 0.044 | ||
| PTK2B | PTK2B protein tyrosine kinase 2 beta | 0.044 | ||
| DDR2 | discoidin domain receptor tyrosine kinase 2 | 0.043 | ||
| LDLR | low density lipoprotein receptor | 0.042 | ||
| FAM46A | family with sequence similarity 46, member A | 0.042 | ||
| STK38L | serine/threonine kinase 38 like | 0.040 | ||
| RASSF5 | Ras association (RalGDS/AF-6) domain family member 5 | 0.040 | ||
| PGR | progesterone receptor | 0.039 | ||
| JUB | jub, ajuba homolog (Xenopus laevis) | 0.038 | ||
| CCNE2 | cyclin E2 | 0.038 | ||
| SPOP | speckle-type POZ protein | 0.038 | ||
| DUSP1 | dual specificity phosphatase 1 | 0.037 | ||
| AR | androgen receptor | 0.037 | ||
| LATS1 | LATS, large tumor suppressor, homolog 1 (Drosophila) | 0.037 | ||
| PARD3 | par-3 partitioning defective 3 homolog (C. elegans) | 0.037 | ||
| STAT3 | signal transducer and activator of transcription 3 (acute-phase response factor) | 0.034 | ||
| SHC1 | SHC (Src homology 2 domain containing) transforming protein 1 | 0.034 | ||
| CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.032 | ||
| FBXW11 | F-box and WD repeat domain containing 11 | 0.032 | ||
| FOXO1 | forkhead box O1 | 0.032 | ||
| PICK1 | protein interacting with PRKCA 1 | 0.031 | ||
| HIF1A | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 0.031 | ||
| PINK1 | PTEN induced putative kinase 1 | 0.031 | ||
| GAB2 | GRB2-associated binding protein 2 | 0.031 | ||
| FASLG | Fas ligand (TNF superfamily, member 6) | 0.031 | ||
| FGF8 | fibroblast growth factor 8 (androgen-induced) | 0.030 | ||
| IGF1R | insulin-like growth factor 1 receptor | 0.030 | ||
| GTF2H1 | general transcription factor IIH, polypeptide 1, 62kDa | 0.030 | ||
| NR4A3 | nuclear receptor subfamily 4, group A, member 3 | 0.030 | ||
| ANKS1B | ankyrin repeat and sterile alpha motif domain containing 1B | 0.030 | ||
| CASP7 | caspase 7, apoptosis-related cysteine peptidase | 0.029 | ||
| HSP90AA1 | heat shock protein 90kDa alpha (cytosolic), class A member 1 | 0.029 | ||
| EGR1 | early growth response 1 | 0.029 | ||
| FOSL2 | FOS-like antigen 2 | 0.029 | Fly | |
| GADD45A | growth arrest and DNA-damage-inducible, alpha | 0.028 | ||
| RAF1 | v-raf-1 murine leukemia viral oncogene homolog 1 | 0.028 | ||
| BRCA1 | breast cancer 1, early onset | 0.028 | ||
| SH2D1A | SH2 domain containing 1A | 0.028 | ||
| KDM6B | lysine (K)-specific demethylase 6B | 0.028 | ||
| SIK1 | salt-inducible kinase 1 | 0.028 | ||
| HBEGF | heparin-binding EGF-like growth factor | 0.027 | ||
| CCNT1 | cyclin T1 | 0.027 | ||
| NFIL3 | nuclear factor, interleukin 3 regulated | 0.027 | ||
| GADD45B | growth arrest and DNA-damage-inducible, beta | 0.027 | ||
| PACSIN3 | protein kinase C and casein kinase substrate in neurons 3 | 0.027 | ||
| ERCC3 | excision repair cross-complementing rodent repair deficiency, complementation group 3 (xeroderma pigmentosum group B complementing) | 0.026 | ||
| ATF4 | activating transcription factor 4 (tax-responsive enhancer element B67) | 0.026 | ||
| TOP3A | topoisomerase (DNA) III alpha | 0.026 | ||
| PARD6A | par-6 partitioning defective 6 homolog alpha (C. elegans) | 0.026 | ||
| TRAP1 | TNF receptor-associated protein 1 | 0.025 | ||
| SENP3 | SUMO1/sentrin/SMT3 specific peptidase 3 | 0.025 | ||
| SESN2 | sestrin 2 | 0.025 | ||
| MAPKAPK2 | mitogen-activated protein kinase-activated protein kinase 2 | 0.025 | ||
| SYK | spleen tyrosine kinase | 0.025 | ||
| MARK2 | MAP/microtubule affinity-regulating kinase 2 | 0.024 | ||
| PSMD7 | proteasome (prosome, macropain) 26S subunit, non-ATPase, 7 | 0.024 | ||
| RFWD2 | ring finger and WD repeat domain 2 | 0.024 | ||
| PTPRB | protein tyrosine phosphatase, receptor type, B | 0.024 | ||
| CRK | v-crk sarcoma virus CT10 oncogene homolog (avian) | 0.024 | ||
| SH3RF1 | SH3 domain containing ring finger 1 | 0.024 | ||
| CCL14 | chemokine (C-C motif) ligand 14 | 0.023 | ||
| EZR | ezrin | 0.023 | ||
| FZR1 | fizzy/cell division cycle 20 related 1 (Drosophila) | 0.023 | ||
| LIMD1 | LIM domains containing 1 | 0.022 | ||
| CDC6 | cell division cycle 6 homolog (S. cerevisiae) | 0.022 | ||
| SAMD4B | sterile alpha motif domain containing 4B | 0.022 | ||
| CDH1 | cadherin 1, type 1, E-cadherin (epithelial) | 0.022 | ||
| MYOD1 | myogenic differentiation 1 | 0.022 | ||
| KIF5B | kinesin family member 5B | 0.022 | ||
| LMNA | lamin A/C | 0.021 | ||
| WDR5 | WD repeat domain 5 | 0.021 | ||
| NR4A1 | nuclear receptor subfamily 4, group A, member 1 | 0.021 | ||
| NR5A2 | nuclear receptor subfamily 5, group A, member 2 | 0.021 | ||
| BTG2 | BTG family, member 2 | 0.020 | ||
| TADA3 | transcriptional adaptor 3 | 0.020 | ||
| S100A2 | S100 calcium binding protein A2 | 0.020 | ||
| SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 0.020 | ||
| SLC9A3R1 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 1 | 0.020 | ||
| SETD7 | SET domain containing (lysine methyltransferase) 7 | 0.020 | ||
| CITED2 | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 | 0.020 | ||
| STC2 | stanniocalcin 2 | 0.020 | ||
| TICAM1 | toll-like receptor adaptor molecule 1 | 0.020 | ||
| GTF2H2 | general transcription factor IIH, polypeptide 2, 44kDa | 0.020 | ||
| ITCH | itchy E3 ubiquitin protein ligase homolog (mouse) | 0.020 | ||
| SREBF2 | sterol regulatory element binding transcription factor 2 | 0.020 | ||
| INSR | insulin receptor | 0.019 | ||
| FRS2 | fibroblast growth factor receptor substrate 2 | 0.019 | ||
| CCHCR1 | coiled-coil alpha-helical rod protein 1 | 0.019 | ||
| CDKN3 | cyclin-dependent kinase inhibitor 3 | 0.019 | ||
| AGFG1 | ArfGAP with FG repeats 1 | 0.019 | ||
| SETDB1 | SET domain, bifurcated 1 | 0.019 | ||
| VIM | vimentin | 0.019 | ||
| MAGEB18 | melanoma antigen family B, 18 | 0.019 | ||
| GORAB | golgin, RAB6-interacting | 0.019 | ||
| ERBB4 | v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian) | 0.018 | Human | |
| YWHAH | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide | 0.018 | ||
| AHR | aryl hydrocarbon receptor | 0.018 | ||
| AMOTL2 | angiomotin like 2 | 0.018 | ||
| TRIM9 | tripartite motif containing 9 | 0.018 | ||
| BCL11A | B-cell CLL/lymphoma 11A (zinc finger protein) | 0.018 | ||
| SASS6 | spindle assembly 6 homolog (C. elegans) | 0.018 | ||
| TGIF1 | TGFB-induced factor homeobox 1 | 0.018 | ||
| RPL23 | ribosomal protein L23 | 0.017 | ||
| RAC1 | ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) | 0.017 | ||
| CD2 | CD2 molecule | 0.017 | ||
| KLF10 | Kruppel-like factor 10 | 0.017 | ||
| MAPK10 | mitogen-activated protein kinase 10 | 0.017 | ||
| GNL3L | guanine nucleotide binding protein-like 3 (nucleolar)-like | 0.017 | ||
| PRKCA | protein kinase C, alpha | 0.017 | ||
| NCOA6 | nuclear receptor coactivator 6 | 0.016 | ||
| MYC | v-myc myelocytomatosis viral oncogene homolog (avian) | 0.016 | ||
| FOSB | FBJ murine osteosarcoma viral oncogene homolog B | 0.016 | Fly | |
| TRO | trophinin | 0.016 | ||
| NDUFB8 | NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 8, 19kDa | 0.016 | ||
| S100B | S100 calcium binding protein B | 0.016 | ||
| RELB | v-rel reticuloendotheliosis viral oncogene homolog B | 0.016 | ||
| RIPK1 | receptor (TNFRSF)-interacting serine-threonine kinase 1 | 0.016 | ||
| IGFBP3 | insulin-like growth factor binding protein 3 | 0.016 | ||
| CSNK2A2 | casein kinase 2, alpha prime polypeptide | 0.016 | ||
| CSRNP1 | cysteine-serine-rich nuclear protein 1 | 0.016 | ||
| DDIT4 | DNA-damage-inducible transcript 4 | 0.016 | ||
| ZAP70 | zeta-chain (TCR) associated protein kinase 70kDa | 0.016 | ||
| KEAP1 | kelch-like ECH-associated protein 1 | 0.016 | ||
| DDX4 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 4 | 0.016 | ||
| GTF2B | general transcription factor IIB | 0.015 | ||
| LIMK1 | LIM domain kinase 1 | 0.015 | ||
| IGFBP5 | insulin-like growth factor binding protein 5 | 0.015 | ||
| VDR | vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.015 | ||
| TSC2 | tuberous sclerosis 2 | 0.015 | ||
| DLG4 | discs, large homolog 4 (Drosophila) | 0.015 | ||
| WRN | Werner syndrome, RecQ helicase-like | 0.015 | ||
| FOXC2 | forkhead box C2 (MFH-1, mesenchyme forkhead 1) | 0.015 | ||
| CDH5 | cadherin 5, type 2 (vascular endothelium) | 0.015 | ||
| SOCS1 | suppressor of cytokine signaling 1 | 0.015 | ||
| GLRX3 | glutaredoxin 3 | 0.015 | ||
| AMOT | angiomotin | 0.015 | ||
| ATRIP | ATR interacting protein | 0.015 | ||
| NRP1 | neuropilin 1 | 0.015 | ||
| GIT2 | G protein-coupled receptor kinase interacting ArfGAP 2 | 0.015 | ||
| ETS2 | v-ets erythroblastosis virus E26 oncogene homolog 2 (avian) | 0.014 | ||
| IKBKB | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta | 0.014 | ||
| SAV1 | salvador homolog 1 (Drosophila) | 0.014 | ||
| ANGPT2 | angiopoietin 2 | 0.014 | ||
| CSNK1D | casein kinase 1, delta | 0.014 | ||
| TEK | TEK tyrosine kinase, endothelial | 0.014 | ||
| KIF23 | kinesin family member 23 | 0.014 | ||
| FGFR3 | fibroblast growth factor receptor 3 | 0.014 | ||
| DLGAP5 | discs, large (Drosophila) homolog-associated protein 5 | 0.014 | ||
| RALGPS2 | Ral GEF with PH domain and SH3 binding motif 2 | 0.014 | ||
| TSR1 | TSR1, 20S rRNA accumulation, homolog (S. cerevisiae) | 0.014 | ||
| EGR3 | early growth response 3 | 0.014 | ||
| USP2 | ubiquitin specific peptidase 2 | 0.014 | ||
| DLG2 | discs, large homolog 2 (Drosophila) | 0.014 | ||
| JDP2 | Jun dimerization protein 2 | 0.014 | Fly | |
| TP53BP2 | tumor protein p53 binding protein, 2 | 0.014 | ||
| ARL6IP1 | ADP-ribosylation factor-like 6 interacting protein 1 | 0.014 | ||
| KPNA1 | karyopherin alpha 1 (importin alpha 5) | 0.014 | ||
| BTBD2 | BTB (POZ) domain containing 2 | 0.014 | ||
| TBX2 | T-box 2 | 0.014 | ||
| RYBP | RING1 and YY1 binding protein | 0.014 | ||
| GMNN | geminin, DNA replication inhibitor | 0.014 | ||
| NUAK1 | NUAK family, SNF1-like kinase, 1 | 0.013 | ||
| IER5 | immediate early response 5 | 0.013 | ||
| ZNF655 | zinc finger protein 655 | 0.013 | ||
| IL4R | interleukin 4 receptor | 0.013 | ||
| SMAD7 | SMAD family member 7 | 0.013 | ||
| COL2A1 | collagen, type II, alpha 1 | 0.013 | ||
| PNMA1 | paraneoplastic antigen MA1 | 0.013 | ||
| FGF2 | fibroblast growth factor 2 (basic) | 0.013 | Human | |
| CSK | c-src tyrosine kinase | 0.013 | ||
| RARG | retinoic acid receptor, gamma | 0.013 | ||
| JAK2 | Janus kinase 2 | 0.013 | ||
| FSTL3 | follistatin-like 3 (secreted glycoprotein) | 0.013 | ||
| PARK2 | parkinson protein 2, E3 ubiquitin protein ligase (parkin) | 0.013 | ||
| SLBP | stem-loop binding protein | 0.013 | ||
| CTBP2 | C-terminal binding protein 2 | 0.013 | ||
| ESRRG | estrogen-related receptor gamma | 0.013 | ||
| STK11 | serine/threonine kinase 11 | 0.013 | ||
| KRT18 | keratin 18 | 0.013 | ||
| TNIP2 | TNFAIP3 interacting protein 2 | 0.013 | ||
| KHDRBS1 | KH domain containing, RNA binding, signal transduction associated 1 | 0.013 | ||
| PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.013 | ||
| RRM2B | ribonucleotide reductase M2 B (TP53 inducible) | 0.012 | ||
| HSPA13 | heat shock protein 70kDa family, member 13 | 0.012 | ||
| USP21 | ubiquitin specific peptidase 21 | 0.012 | ||
| RHOB | ras homolog gene family, member B | 0.012 | ||
| COL5A1 | collagen, type V, alpha 1 | 0.012 | ||
| CHGB | chromogranin B (secretogranin 1) | 0.012 | ||
| CSF2RB | colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage) | 0.012 | ||
| COL6A1 | collagen, type VI, alpha 1 | 0.012 | ||
| MKL2 | MKL/myocardin-like 2 | 0.012 | Human | |
| TNFRSF1A | tumor necrosis factor receptor superfamily, member 1A | 0.012 | ||
| CLSPN | claspin | 0.012 | ||
| ABL2 | v-abl Abelson murine leukemia viral oncogene homolog 2 | 0.012 | ||
| HIPK3 | homeodomain interacting protein kinase 3 | 0.012 | ||
| WAS | Wiskott-Aldrich syndrome (eczema-thrombocytopenia) | 0.012 | ||
| TLE1 | transducin-like enhancer of split 1 (E(sp1) homolog, Drosophila) | 0.012 | ||
| BRIX1 | BRX1, biogenesis of ribosomes, homolog (S. cerevisiae) | 0.012 | ||
| ZC3H12A | zinc finger CCCH-type containing 12A | 0.012 | ||
| PSMF1 | proteasome (prosome, macropain) inhibitor subunit 1 (PI31) | 0.012 | ||
| MTOR | mechanistic target of rapamycin (serine/threonine kinase) | 0.011 | ||
| LCP2 | lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) | 0.011 | ||
| EEF2K | eukaryotic elongation factor-2 kinase | 0.011 | ||
| NADK | NAD kinase | 0.011 | ||
| ATF2 | activating transcription factor 2 | 0.011 | ||
| IL9R | interleukin 9 receptor | 0.011 | ||
| TUBB2B | tubulin, beta 2B | 0.011 | ||
| DLG3 | discs, large homolog 3 (Drosophila) | 0.011 | ||
| C19orf6 | chromosome 19 open reading frame 6 | 0.011 | ||
| MUC1 | mucin 1, cell surface associated | 0.011 | ||
| FRK | fyn-related kinase | 0.011 | ||
| RGS1 | regulator of G-protein signaling 1 | 0.011 | ||
| SATB1 | SATB homeobox 1 | 0.011 | ||
| NTRK1 | neurotrophic tyrosine kinase, receptor, type 1 | 0.011 | ||
| PRKCE | protein kinase C, epsilon | 0.011 | ||
| SORBS2 | sorbin and SH3 domain containing 2 | 0.011 | ||
| FKBP3 | FK506 binding protein 3, 25kDa | 0.011 | ||
| PIAS4 | protein inhibitor of activated STAT, 4 | 0.011 | ||
| ZNF71 | zinc finger protein 71 | 0.011 | ||
| MYCN | v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian) | 0.011 | ||
| HSPG2 | heparan sulfate proteoglycan 2 | 0.011 | ||
| USP7 | ubiquitin specific peptidase 7 (herpes virus-associated) | 0.011 | ||
| FLT4 | fms-related tyrosine kinase 4 | 0.011 | ||
| AMY2A | amylase, alpha 2A (pancreatic) | 0.011 | ||
| RAD52 | RAD52 homolog (S. cerevisiae) | 0.011 | ||
| RNF17 | ring finger protein 17 | 0.011 | ||
| PURA | purine-rich element binding protein A | 0.011 | ||
| NFATC1 | nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 | 0.011 | ||
| STK38 | serine/threonine kinase 38 | 0.011 | ||
| MED1 | mediator complex subunit 1 | 0.011 | ||
| TERF2 | telomeric repeat binding factor 2 | 0.011 | ||
| NEDD9 | neural precursor cell expressed, developmentally down-regulated 9 | 0.011 | ||
| ANKRD28 | ankyrin repeat domain 28 | 0.011 | ||
| E2F4 | E2F transcription factor 4, p107/p130-binding | 0.011 | ||
| MAP1LC3A | microtubule-associated protein 1 light chain 3 alpha | 0.011 | ||
| DAXX | death-domain associated protein | 0.011 | ||
| DIAPH1 | diaphanous homolog 1 (Drosophila) | 0.011 | ||
| HIPK2 | homeodomain interacting protein kinase 2 | 0.011 | ||
| TAF1 | TAF1 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 250kDa | 0.011 | ||
| MMP16 | matrix metallopeptidase 16 (membrane-inserted) | 0.011 | ||
| MOBKL1B | MOB1, Mps One Binder kinase activator-like 1B (yeast) | 0.011 | ||
| CACNA1B | calcium channel, voltage-dependent, N type, alpha 1B subunit | 0.011 | ||
| TWIST1 | twist homolog 1 (Drosophila) | 0.011 | ||
| PIP4K2B | phosphatidylinositol-5-phosphate 4-kinase, type II, beta | 0.011 | ||
| PTK2 | PTK2 protein tyrosine kinase 2 | 0.010 | ||
| RAI1 | retinoic acid induced 1 | 0.010 | ||
| RBBP5 | retinoblastoma binding protein 5 | 0.010 | ||
| USF1 | upstream transcription factor 1 | 0.010 | ||
| ADAM10 | ADAM metallopeptidase domain 10 | 0.010 | ||
| TAL1 | T-cell acute lymphocytic leukemia 1 | 0.010 | ||
| RPS27L | ribosomal protein S27-like | 0.010 | ||
| WNT1 | wingless-type MMTV integration site family, member 1 | 0.010 | ||
| NR2F2 | nuclear receptor subfamily 2, group F, member 2 | 0.010 | ||
| E2F3 | E2F transcription factor 3 | 0.010 | ||
| CEBPA | CCAAT/enhancer binding protein (C/EBP), alpha | 0.010 |